285 related articles for article (PubMed ID: 16490518)
1. Severe steroid-induced glaucoma following intravitreal injection of triamcinolone acetonide.
Quiram PA; Gonzales CR; Schwartz SD
Am J Ophthalmol; 2006 Mar; 141(3):580-2. PubMed ID: 16490518
[TBL] [Abstract][Full Text] [Related]
2. Complications of intravitreal steroid injections.
Reichle ML
Optometry; 2005 Aug; 76(8):450-60. PubMed ID: 16150412
[TBL] [Abstract][Full Text] [Related]
3. Intravitreal triamcinolone acetonide treatment of macular edema associated with central retinal vein occlusion.
Goff MJ; Jumper JM; Yang SS; Fu AD; Johnson RN; McDonald HR; Ai E
Retina; 2006 Oct; 26(8):896-901. PubMed ID: 17031289
[TBL] [Abstract][Full Text] [Related]
4. Repeated intravitreal high-dosage injections of triamcinolone acetonide for diffuse diabetic macular edema.
Jonas JB; Spandau UH; Kamppeter BA; Vossmerbaeumer U; Harder B; Sauder G
Ophthalmology; 2006 May; 113(5):800-4. PubMed ID: 16530840
[TBL] [Abstract][Full Text] [Related]
5. Intravitreal triamcinolone for refractory diabetic macular edema: two-year results of a double-masked, placebo-controlled, randomized clinical trial.
Gillies MC; Sutter FK; Simpson JM; Larsson J; Ali H; Zhu M
Ophthalmology; 2006 Sep; 113(9):1533-8. PubMed ID: 16828501
[TBL] [Abstract][Full Text] [Related]
6. Intractable glaucoma following intravitreal triamcinolone in central retinal vein occlusion.
Kaushik S; Gupta V; Gupta A; Dogra MR; Singh R
Am J Ophthalmol; 2004 Apr; 137(4):758-60. PubMed ID: 15059722
[TBL] [Abstract][Full Text] [Related]
7. Malignant glaucoma as a complication of intravitreal triamcinolone acetonide.
Heatley CJ; Lim KS; Siriwardena D; Barton K
Acta Ophthalmol Scand; 2006 Oct; 84(5):712-3. PubMed ID: 16965510
[No Abstract] [Full Text] [Related]
8. Selective laser trabeculoplasty for intraocular pressure elevation after intravitreal triamcinolone acetonide injection.
Pizzimenti JJ; Nickerson MM; Pizzimenti CE; Kasten-Aker AG
Optom Vis Sci; 2006 Jul; 83(7):421-5. PubMed ID: 16840867
[TBL] [Abstract][Full Text] [Related]
9. Intravitreal triamcinolone acetonide for diffuse diabetic macular oedema: 6-month results of a prospective controlled trial.
Audren F; Erginay A; Haouchine B; Benosman R; Conrath J; Bergmann JF; Gaudric A; Massin P
Acta Ophthalmol Scand; 2006 Oct; 84(5):624-30. PubMed ID: 16965492
[TBL] [Abstract][Full Text] [Related]
10. One-year safety and efficacy of intravitreal triamcinolone acetonide for the management of macular edema secondary to central retinal vein occlusion.
Gregori NZ; Rosenfeld PJ; Puliafito CA; Flynn HW; Lee JE; Mavrofrides EC; Smiddy WE; Murray TG; Berrocal AM; Scott IU; Gregori G
Retina; 2006 Oct; 26(8):889-95. PubMed ID: 17031288
[TBL] [Abstract][Full Text] [Related]
11. Cataract formation and other complications of intravitreal triamcinolone for macular edema.
Thompson JT
Am J Ophthalmol; 2006 Apr; 141(4):629-37. PubMed ID: 16564796
[TBL] [Abstract][Full Text] [Related]
12. Vitrectomy as a treatment for elevated intraocular pressure following intravitreal injection of triamcinolone acetonide.
Agrawal S; Agrawal J; Agrawal TP
Am J Ophthalmol; 2004 Oct; 138(4):679-80. PubMed ID: 15488813
[TBL] [Abstract][Full Text] [Related]
13. Posterior hyaloid changes following intravitreal triamcinolone and macular laser for diffuse diabetic macular edema.
Sivaprasad S; Ockrim Z; Massaoutis P; Ikeji F; Hykin PG; Gregor ZJ
Retina; 2008; 28(10):1435-42. PubMed ID: 18628722
[TBL] [Abstract][Full Text] [Related]
14. Persistent triamcinolone acetonide particles on the posterior lens capsule after intravitreal injection.
Sakalar YB; Unlu K; Keklikci U; Caca I; Senol BB
Ann Ophthalmol (Skokie); 2008; 40(3-4):190-2. PubMed ID: 19230363
[TBL] [Abstract][Full Text] [Related]
15. Micropulsed laser photocoagulation and intravitreal triamcinolone acetonide injection for the treatment of retinal angiomatous proliferation.
Roth DB; Scott IU; Gloth JM; Green SN; Yarian DL; Wheatley M
Retina; 2007; 27(9):1201-4. PubMed ID: 18046225
[TBL] [Abstract][Full Text] [Related]
16. Herpes simplex keratitis after intravitreal triamcinolone acetonide.
Shtein RM; Stahl RM; Saxe SJ; Mian SI
Cornea; 2007 Jun; 26(5):641-2. PubMed ID: 17525670
[TBL] [Abstract][Full Text] [Related]
17. Refractory ocular hypertension secondary to intravitreal injection of triamcinolone acetonide.
Detry-Morel M; Escarmelle A; Hermans I
Bull Soc Belge Ophtalmol; 2004; (292):45-51. PubMed ID: 15253490
[TBL] [Abstract][Full Text] [Related]
18. Early rapid rise in intraocular pressure after intravitreal triamcinolone acetonide injection.
Singh IP; Ahmad SI; Yeh D; Challa P; Herndon LW; Allingham RR; Lee PP
Am J Ophthalmol; 2004 Aug; 138(2):286-7. PubMed ID: 15289140
[TBL] [Abstract][Full Text] [Related]
19. A case of herpetic keratitis after intravitreal triamcinolone injection.
Gulkilik G; Demirci G; Ozdamar AM; Muftuoglu GI
Cornea; 2007 Sep; 26(8):1000-1. PubMed ID: 17721305
[TBL] [Abstract][Full Text] [Related]
20. Posterior subtenon and intravitreal triamcinolone acetonide for diabetic macular edema.
Ozdek S; Bahçeci UA; Gürelik G; Hasanreisoğlu B
J Diabetes Complications; 2006; 20(4):246-51. PubMed ID: 16798476
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
